Evidence map›Paper›PMID 36084422›Full record

ArticleDiagnostic microbiology and infectious disease2022

An external quality assessment for the molecular testing of the SARS-CoV-2 virus genome in Zhejiang Province, China.

Junhang Pan, Hao Yan, Zhen Li, Xiuyu Lou, Haiyan Mao, Wen Shi, Wenwu Yao, Yanjun Zhang

Abstract read
In one paragraph

Article in Diagnostic microbiology and infectious disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Junhang PanZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang Province, China.
Hao YanZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang Province, China.
Zhen LiZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang Province, China.
Xiuyu LouZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang Province, China.
Haiyan MaoZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang Province, China.
Wen ShiZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang Province, China.
Wenwu YaoZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang Province, China.
Yanjun ZhangZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang Province, China. Electronic address: yjzhang@cdc.zj.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic has necessitated the rapid expansion of laboratories that conduct SARS-CoV-2 tests. A provincial external quality assessment (EQA) scheme on SARS-CoV-2 tests was organized by Zhejiang Provincial CDC to assess the accuracy of the tests in individual CDC municipal and county laboratories in Zhejiang Province, China. Three positive samples in high, medium, and low concentrations, respectively, were prepared using the serial dilutions from the culture with the viral titer concentration of 1×10

Indexed as

COVID-19Nucleic AcidsHumansMolecular Diagnostic TechniquesPandemicsSARS-CoV-2Nucleic AcidsCOVID-19external quality assessmentmolecular diagnosticsSARS-CoV-2

Identifiers

PMID36084422
PMCPMC9297680

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.